Skip to main content

Find Clinical Trials

Home
Conditions
Reoviridae Infections

Clinical trial condition

Reoviridae Infections

Explore clinical trials studying Reoviridae Infections. Study availability and eligibility vary by location and protocol.

90 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Reoviridae Infections trial results

Completed

Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama

NCT00653198

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Panama City, Panama

View Trial Details

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

NCT02538211

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +14 more
Locations: Academic Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

NCT00289172

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Chandigarth, India

GSK Investigational Site Kolkata, India

GSK Investigational Site Pune, India

GSK Investigational Site Vellore, India

View Trial Details

Completed

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

NCT01162590

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Liucheng County, Guangxi, China

View Trial Details

Completed

Study to Evaluate the Safety of Rotarix™ in Chinese Children

NCT01086436

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Liucheng County, Guangxi, China

View Trial Details

Completed

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

NCT01107587

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Liucheng County, Guangxi, China

View Trial Details

Completed

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

NCT01511133

Conditions: Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants, Infections, RNA Virus Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

NCT00370318

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations: GSK Investigational Site Brno, Czechia

GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Jindřichův Hradec, Czechia

GSK Investigational Site Náchod, Czechia

View Trial Details

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

NCT00140686

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Brno, Czechia

GSK Investigational Site Havlíčkův Brod, Czechia

GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Humpolec, Czechia

View all 101 locations

View Trial Details

Completed

Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium

NCT01339221

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Brussels, Belgium

GSK Investigational Site Deurne, Belgium

GSK Investigational Site Eeklo, Belgium

View Trial Details